![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 39/00 | (2006.01) |
(11) | Number of the document | 2872171 |
(13) | Kind of document | T |
(96) | European patent application number | 13817210.1 |
Date of filing the European patent application | 2013-07-12 | |
(97) | Date of publication of the European application | 2015-05-20 |
(45) | Date of publication and mention of the grant of the patent | 2021-01-06 |
(46) | Date of publication of the claims translation | 2021-04-26 |
(86) | Number | PCT/US2013/050267 |
Date | 2013-07-12 |
(87) | Number | WO 2014/011984 |
Date | 2014-01-16 |
(30) | Number | Date | Country code |
201261671482 P | 2012-07-13 | US | |
201361782982 P | 2013-03-14 | US |
(72) |
JUNE, Carl, H., US
LEVINE, Bruce, L., US
KALOS, Michael D., US
GRUPP, Stephan, US
|
(73) |
The Children`s Hospital of Philadelphia,
34th and Civic Center Boulevard, Philadelphia, PA 19104,
US
The Trustees of The University of Pennsylvania, Center for Technology Transfer 3160 Chestnut Street, Suite 200, Philadelphia PA 19104-6283, US |
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | CAR priešnavikinio aktyvumo toksiškumo reguliavimas |
TOXICITY MANAGEMENT FOR ANTI-TUMOR ACTIVITY OF CARS |
Payment date | Validity (years) | Amount | |
2025-06-04 | 13 | 289.00 EUR |
2026-07-12 |